Search

Your search keyword '"Csajka, Chantal"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Csajka, Chantal" Remove constraint Author: "Csajka, Chantal" Publisher springer nature Remove constraint Publisher: springer nature
26 results on '"Csajka, Chantal"'

Search Results

1. Predicting delirium in older non-intensive care unit inpatients: development and validation of the DELIrium risK Tool (DELIKT).

2. Impact of Pharmaceutical Interventions with STOPP/START and PIM-Check in Older Hospitalized Patients: A Randomized Controlled Trial.

3. Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland.

4. Ability to detect potentially inappropriate prescribing in older patients: comparative analysis between PIM-Check and STOPP/STARTv2.

5. Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration.

6. Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs.

7. Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV.

8. Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review.

9. Influence of Drug–Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV.

10. Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic Analyses.

11. Towards Personalized Antithrombotic Treatments: Focus on P2Y12 Inhibitors and Direct Oral Anticoagulants.

12. Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population.

14. Using a structured reconciliation medication form improves medication transition from hospital to community care and primary care physicians' adherence with medication adaptations and recommendations.

15. Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients.

16. Effect of Adherence on Pharmacokinetic/Pharmacodynamic Relationships of Oral Targeted Anticancer Drugs.

17. Population Genetic-Based Pharmacokinetic Modeling of Methadone and its Relationship with the QTc Interval in Opioid-Dependent Patients.

18. Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort.

20. Quantitative monitoring of tamoxifen in human plasma extended to 40 metabolites using liquid-chromatography high-resolution mass spectrometry: new investigation capabilities for clinical pharmacology.

21. Population Pharmacokinetic Study of Memantine: Effects of Clinical and Genetic Factors.

22. Benchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools.

23. Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels.

24. Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents.

25. Population pharmacokinetic-pharmacodynamic modelling of angiotensin receptor blockade in healthy volunteers.

26. Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients.

Catalog

Books, media, physical & digital resources